These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ketoprofen (Orudis) in ankylosing spondylitis. Treadwell BL; Tweed JM N Z Med J; 1975 May; 81(539):411-3. PubMed ID: 1099489 [TBL] [Abstract][Full Text] [Related]
6. Association of renal papillary necrosis and ankylosing spondylitis. Lourie SH; Denman SJ; Schroeder ET Arthritis Rheum; 1977 May; 20(4):917-21. PubMed ID: 861066 [TBL] [Abstract][Full Text] [Related]
7. The treatment of ankylosing spondylitis. Golding JR Practitioner; 1972 Jan; 208(243):57-63. PubMed ID: 5015132 [No Abstract] [Full Text] [Related]
8. Phenylbutazone can spuriously elevate unextracted testosterone assay results in patients with ankylosing spondylitis. Giltay EJ; Popp-Snijders C; van Denderen JC; van Schaardenburg D; Gooren LJ; Dijkmans BA J Clin Endocrinol Metab; 2000 Dec; 85(12):4923-4. PubMed ID: 11134168 [No Abstract] [Full Text] [Related]
9. [Etiology of human leukemias]. Mey U Z Gesamte Inn Med; 1974 Jul; 29(14):559-63. PubMed ID: 4605659 [No Abstract] [Full Text] [Related]
10. Phenylbutazone and oxyphenbutazone. Med Lett Drugs Ther; 1973 Apr; 15(9):40. PubMed ID: 4704701 [No Abstract] [Full Text] [Related]
11. [Incidence of complications in the drug treatment of ankylosing spondylitis]. Svec V; Ondrasík M Bratisl Lek Listy; 1971 May; 55(5):619-28. PubMed ID: 5582085 [No Abstract] [Full Text] [Related]
12. Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis. Lignière GC; Colombo B; Carrabba M; Ferrari P; Robotti E Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:253-8. PubMed ID: 4553232 [No Abstract] [Full Text] [Related]
13. [Clinical significance of restricted respiratory function in ankylosing spondylitis]. Ozalp M; Weimann G Z Rheumatol; 1974; 33(5):214-22. PubMed ID: 4368081 [No Abstract] [Full Text] [Related]
14. [Spondylarthritis ankylopoietica and autoimmune hemolytic anemia]. Ribera JM; Bladé J; Feliu E; Rozman C Med Clin (Barc); 1983 May; 80(18):815-6. PubMed ID: 6633028 [No Abstract] [Full Text] [Related]
15. A comparative study of Butacote and naproxen in ankylosing spondylitis. Ansell BM J Int Med Res; 1977; 5 Suppl 2():95. PubMed ID: 334610 [No Abstract] [Full Text] [Related]
16. [Improved compatibility of phenylbutazone drugs. A new antirheumatic agent in sugar-coated tablets, suppositories, ampoules]. Dürrigl T; Vitaus M Munch Med Wochenschr; 1969 Mar; 111(10):564-8. PubMed ID: 4239143 [No Abstract] [Full Text] [Related]
17. A controlled study of flufenamic acid in ankylosing spondylitis. A final report and follow-up study. Simpson MR; Simpson NR; Masheter HC Ann Phys Med; 1968 May; 9(6):229-33. PubMed ID: 5655416 [No Abstract] [Full Text] [Related]
18. [Our experience with Klinoril in the treatment of ankylosing spondylitis]. Jajić I Reumatizam; 1977; 24(2):51-6. PubMed ID: 854658 [No Abstract] [Full Text] [Related]
20. Ankylosing spondylitis: a late re-evaluation of 92 cases. Kinsella TD; MacDonald RF; Johnson LG Can Med Assoc J; 1966 Jul; 95(1):1-9. PubMed ID: 5943693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]